Expert Opinion on Drug Metabolism & Toxicology

期刊全称Expert Opinion on Drug Metabolism & Toxicology
期刊缩写Expert Opin. Drug Metab. Toxicol.
涉及主题医学生物内科学药理学化学遗传学生物化学心理学生物信息学精神科药品内分泌学有机化学药代动力学病理基因物理重症监护医学核磁共振
期刊介绍

Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data. Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug. The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.

期刊ISSNprint: 1742-5255
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
3.94.34.9364.4813.473.4873.1513.027
历年发表/被引量
年份20252024202320222021202020192018201720162015201420132012
发表量5011188618312077108102166144155142134
被引量24085816630864716587614547464561441641763677347033783179
h-Index72
自引率2.60%
涉及的研究领域医学-生化与分子生物学
中科院2025年分区 ?
大类小类TOP期刊综述期刊
3区2区 毒理学
3区生化与分子生物学
3区药学
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ2137/319
PHARMACOLOGY & PHARMACYSCIEQ2113/352
TOXICOLOGYSCIEQ234/106

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ3222/320
PHARMACOLOGY & PHARMACYSCIEQ3221/353
TOXICOLOGYSCIEQ378/106
期刊主页http://www.tandfonline.com/loi/iemt20#.V48aFkz9cSQhttp://www.tandfonline.com/iemt
投稿网址https://mc.manuscriptcentral.com/eomt
出版商Taylor and Francis Ltd.
出版国家(地区)ENGLAND
出版语言English
出版周期Bimonthly
每年出版文章数74
Gold OA文章占比16.28%
原创研究文献占比
(排除综述)
12.90%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1742-5255%5BISSN%5D
平均审稿周期偏慢,4-8周
平均录用比例较易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈